CAPLYTA Q3 2024 net product sales were $175.2 million, compared to $125.8 million for the same period in 2023, representing a 39% increase CAPLYTA’s strong prescription uptake continues ...
The company’s sales for Caplyta in the third quarter of 2024 amounted to $175.2 million, slightly surpassing market expectations, which indicates robust demand and positive market reception.
A wash sale is a transaction in which an investor sells a losing security to claim a capital loss, and within 30 days before or after the sale, they: Buy substantially the same securities ...
(NYSE, Nasdaq: NYSE:VZ) for $1 billion in cash. This transaction is part of UScellular's previously announced strategy to monetize spectrum assets. The deal with Verizon involves the sale of 663 ...
Verizon Communications Inc., the biggest wireless carrier in the US, will buy some of US Cellular Corp.’s spectrum licenses for $1 billion as the tower operator sheds parts of its portfolio.
The deal with Verizon involves the sale of 663 million MHz POPs of UScellular's Cellular (850 MHz) spectrum licenses, along with 11 million MHz POPs of its AWS and 19 million MHz POPs of its PCS ...
U.S. stocks were mixed , with the Nasdaq Composite gaining around 100 points on Friday. The company reported third-quarter adjusted earnings per share of $1.84, missing the analyst consensus of $1 ...